FDA slams Eli Lilly's 'misleading' Instagram ad for its type 2 diabetes injection
In a first for 2022, the FDA’s Office of Prescription Drug Promotion has issued an untitled letter, which was recently sent …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
